Stock · B3 · public data

DEXP4

DEXXOS PAR · Químicos

Reference priceR$8.00Updated according to the public source
P/E6.76
P/B0.90
ROE13.35%
DY 12M6.37%
Net margin8.16%
Net debt/equity-0.07
Market capR$ 980.8 M
Volume (shares)24,403
SectorQuímicos
Overview

About DEXP4

Indicadores públicos consolidados

DEXXOS PAR (DEXP4) is a company listed on B3 in the Químicos sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

No financial statements are available from the consulted sources; missing figures must not be interpreted as zero.

Distributions

Dividends and distributions · last 12 records

public data

The source returned no recent distributions for this asset.

Financials

Income statement, balance sheet and cash flow

No data

Financial statements are not available for this asset yet.

FAQ

Frequently asked questions

What is the price of DEXP4?

The reference price available for DEXP4 is R$8.00.

What is the P/E of DEXP4?

The P/E ratio of DEXP4 is 6.76. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of DEXP4?

The P/B of DEXP4 is 0.90. This compares price with reported book value per share.

What is the ROE of DEXP4?

The ROE (Return on Equity) of DEXP4 is 13.35%. This relates the reported net result to shareholders' equity.

What is the dividend yield of DEXP4?

The dividend yield of DEXP4 is 6.37%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of DEXP4?

The market capitalization of DEXP4 is R$ 980.8 M.

What is the net margin of DEXP4?

The net profit margin of DEXP4 is 8.16%. This relates the reported net result to revenue.

What is the net debt-to-equity ratio of DEXP4?

The reported net debt-to-equity ratio of DEXP4 is -0.07. This compares net debt, after cash, with shareholders' equity.

What sector is DEXP4 in?

DEXP4 operates in the Químicos sector.

FundamentalRadar · educational information, not investment advice.